HALO
$95.97-0.55%
as of close, Nov 17, 2026
☾ AH $95.97 -0.55%
Halozyme Therapeutics Inc.Stock · HealthcareNasdaq Composite · 0.03% of ONEQRussell 3000 · 0.01% of IWVRussell 1000 · 0.01% of IWBUS Stock Market · 0.01% of VTI
Head-to-head:Compare with INCY or any ticker →
Halozyme Therapeutics Inc. total returns by year (including dividends)
As of market close, Nov 17, 2026
Every year since 2004#
Data provided bySource: Twelve DataCalendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start | End | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $67.30 | $95.97 | 0.0% | +42.6% | |
| 2025 | $47.81 | $67.30 | 0.0% | +40.8% | |
| 2024 | $36.96 | $47.81 | 0.0% | +29.4% | |
| 2023 | $56.90 | $36.96 | 0.0% | -35.0% | |
| 2022 | $40.21 | $56.90 | 0.0% | +41.5% | |
| 2021 | $42.71 | $40.21 | 0.0% | -5.9% | |
| 2020 | $17.73 | $42.71 | 0.0% | +140.9% | |
| 2019 | $14.63 | $17.73 | 0.0% | +21.2% | |
| 2018 | $20.26 | $14.63 | 0.0% | -27.8% | |
| 2017 | $9.88 | $20.26 | 0.0% | +105.1% | |
| 2016 | $17.33 | $9.88 | 0.0% | -43.0% | |
| 2015 | $9.65 | $17.33 | 0.0% | +79.6% | |
| 2014 | $14.99 | $9.65 | 0.0% | -35.6% | |
| 2013 | $6.71 | $14.99 | 0.0% | +123.4% | |
| 2012 | $9.51 | $6.71 | 0.0% | -29.4% | |
| 2011 | $7.92 | $9.51 | 0.0% | +20.1% | |
| 2010 | $5.87 | $7.92 | 0.0% | +34.9% | |
| 2009 | $5.60 | $5.87 | 0.0% | +4.8% | |
| 2008 | $7.11 | $5.60 | 0.0% | -21.2% | |
| 2007 | $8.05 | $7.11 | 0.0% | -11.7% | |
| 2006 | $1.82 | $8.05 | 0.0% | +342.3% | |
| 2005 | $2.20 | $1.82 | 0.0% | -17.3% | |
| 2004since Mar 16 | $4.25 | $2.20 | 0.0% | -48.2% |
- Annualized
- +14.6%
- 2005–2026
- Average year
- +36.0%
- 21 full years
- Best year
- +342.3%
- 2006
- Worst year
- -43.0%
- 2016
- Positive years
- 12/21
- 57% up
Annualized (CAGR)
+14.6%
2005–2026
Average year
+36.0%
21 full years
Best year
+342.3%
2006
Worst year
-43.0%
2016
Positive years
12/21
57% up
Total return by period#
Annual
−400%−200%0%200%400%
2004, since Mar 16-48%'04
2005-17%
2006+342%'06
2007-12%
2008-21%'08
2009+4.8%
2010+35%'10
2011+20%
2012-29%'12
2013+123%
2014-36%'14
2015+80%
2016-43%'16
2017+105%
2018-28%'18
2019+21%
2020+141%'20
2021-5.9%
2022+42%'22
2023-35%
2024+29%'24
2025+41%
2026+43%'26
Methodology#
Total returns, dividends reinvested, measured on HALO. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Halozyme Therapeutics Inc.'s average annual return?
- Since 2005, Halozyme Therapeutics Inc. (HALO) has returned about 14.6% a year (the compound annual growth rate) and an average calendar-year return of 36.0%.
- What were Halozyme Therapeutics Inc.'s best and worst years?
- Over 2005–2026, the best year was 2006 (+342.3%) and the worst was 2016 (-43.0%).
- How often is Halozyme Therapeutics Inc. up in a year?
- 12 of the 21 full years since 2005 were positive — about 57% of the time.
More on Halozyme Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100
Head-to-head:Compare with INCY or any ticker →
